Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H S Feigelson

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Cancer Causes & Control : CCC|January 26, 2002
Alcohol consumption increases the risk of fatal breast cancer (United States)H S Feigelson, E E Calle, A S Robertson, et al.
Journal of Clinical Epidemiology|February 1, 1996
IgE predicts future nonfatal myocardial infarction in menR D Langer, M H Criqui, H S Feigelson, et al.
Cancer Research|March 15, 1997
A polymorphism in the CYP17 gene increases the risk of breast cancerH S Feigelson, G A Coetzee, L N Kolonel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
Declining cancer rates in the 1990sR McKean-Cowdin, H S Feigelson, R K Ross, et al.
Cancer Research|February 24, 2001
Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidatesH S Feigelson, R McKean-Cowdin, G A Coetzee, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1996
Genetic susceptibility to cancer from exogenous and endogenous exposuresH S Feigelson, R K Ross, M C Yu, et al.
Clinical Genetics|July 1, 1997
A polymorphism in intron 6 of the CYP17 geneL E Crocitto, H S Feigelson, M C Yu, et al.
Cancer Research|March 4, 1998
Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrationsH S Feigelson, L S Shames, M C Pike, et al.
Drug Metabolism Reviews|June 2, 1998
Sex steroid hormones and genetic susceptibility to breast and prostate cancerH S Feigelson, R K Ross, M C Yu, et al.
Cancer Research|February 28, 2001
Risk of endometrial cancer and estrogen replacement therapy history by CYP17 genotypeR McKean-Cowdin, H S Feigelson, M C Pike, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Cancer Causes & Control : CCC|January 26, 2002
Alcohol consumption increases the risk of fatal breast cancer (United States)H S Feigelson, E E Calle, A S Robertson, et al.
Journal of Clinical Epidemiology|February 1, 1996
IgE predicts future nonfatal myocardial infarction in menR D Langer, M H Criqui, H S Feigelson, et al.
Cancer Research|March 15, 1997
A polymorphism in the CYP17 gene increases the risk of breast cancerH S Feigelson, G A Coetzee, L N Kolonel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
Declining cancer rates in the 1990sR McKean-Cowdin, H S Feigelson, R K Ross, et al.
Cancer Research|February 24, 2001
Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidatesH S Feigelson, R McKean-Cowdin, G A Coetzee, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1996
Genetic susceptibility to cancer from exogenous and endogenous exposuresH S Feigelson, R K Ross, M C Yu, et al.
Clinical Genetics|July 1, 1997
A polymorphism in intron 6 of the CYP17 geneL E Crocitto, H S Feigelson, M C Yu, et al.
Cancer Research|March 4, 1998
Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrationsH S Feigelson, L S Shames, M C Pike, et al.
Drug Metabolism Reviews|June 2, 1998
Sex steroid hormones and genetic susceptibility to breast and prostate cancerH S Feigelson, R K Ross, M C Yu, et al.
Cancer Research|February 28, 2001
Risk of endometrial cancer and estrogen replacement therapy history by CYP17 genotypeR McKean-Cowdin, H S Feigelson, M C Pike, et al.
Pageof 3